<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90792">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02004353</url>
  </required_header>
  <id_info>
    <org_study_id>CEL 5277</org_study_id>
    <nct_id>NCT02004353</nct_id>
  </id_info>
  <brief_title>Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear</brief_title>
  <acronym>IROS</acronym>
  <official_title>Cochlear-Implanted Recipient Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <authority>Poland: Ethics Committee</authority>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect patient related benefit data following treatment for
      permanent hearing loss with a hearing implant from the company Cochlear over a period of 2
      years post treatment.

      Assessment of benefits is based on standard questionnaires of hearing ability and quality of
      life in general.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical investigation is designed as a prospective repeated measures longitudinal study
      with intra-subject controls, using a selection of subjective evaluation tools to assess
      patient related benefits from hearing implant treatment of permanent hearing loss.

      Clinically standard self-assessment scales, threshold measures and a general hearing history
      profile questionnaires for the clinician and implant recipient are made available for
      selection through an interface to a central electronic platform.

      The registry is aimed at collection of data for patients who have already made the decision
      together with their implant centre clinician for an implant device from the company
      Cochlear.

      Patients are approached for registry participation following implant by the caring clinician
      on a consecutive and voluntary basis and on condition of signing the patient informed
      consent.

      Monitoring of data entry is included through automated reminders via e-platform and through
      inherent audit trail.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Patient Related Benefits - Improvements in Hearing ability assessed via Speech Spatial Hearing Qualities questionnaire</measure>
    <time_frame>Baseline (i.e. pre-implanted status) assessed prior to 1st switch-on</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Related Benefits - Improvements in Hearing ability assessed via Speech Spatial Hearing Qualities questionnaire</measure>
    <time_frame>post-implant at 1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Related Benefits - Improvements in Hearing ability assessed via Speech Spatial Hearing Qualities questionnaire</measure>
    <time_frame>post-implant at 2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Related Benefits- Improvement in general quality of life assessed via Health Utility Index Mark III questionnaire</measure>
    <time_frame>Baseline (i.e. pre-implanted status) assessed prior to 1st switch-on</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Related Benefits- Improvement in general quality of life assessed via Health Utility Index Mark III questionnaire</measure>
    <time_frame>post-implant at 1year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Related Benefits- Improvement in general quality of life assessed via Health Utility Index Mark III questionnaire</measure>
    <time_frame>post-implant at 2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unaided hearing thresholds</measure>
    <time_frame>Baseline (i.e. pre-implant status) assessed prior to 1st switch-on</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unaided hearing thresholds for bone and air conduction  for the implanted and non-implanted ear to monitor clinically significant changes over time for frequencies between 125Hz and 8000 Hz</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unaided hearing thresholds</measure>
    <time_frame>immediately post-implant (optional)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unaided hearing thresholds for bone and air conduction  for the implanted and non-implanted ear to monitor clinically significant changes over time for frequencies between 125Hz and 8000 Hz</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unaided hearing thresholds</measure>
    <time_frame>post-implant at 1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unaided hearing thresholds for bone and air conduction  for the implanted and non-implanted ear to monitor clinically significant changes over time for frequencies between 125Hz and 8000 Hz</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unaided hearing thresholds</measure>
    <time_frame>post-implant at 2 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unaided hearing thresholds for bone and air conduction  for the implanted and non-implanted ear to monitor clinically significant changes over time for frequencies between 125Hz and 8000 Hz</description>
  </secondary_outcome>
  <other_outcome>
    <measure>General Patient Hearing Profile Information</measure>
    <time_frame>Baseline (i.e. pre-implant status) assessed prior to 1st switch-on</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Patient Hearing Profile Information related  to hearing history and daily hearing device use</description>
  </other_outcome>
  <other_outcome>
    <measure>General Patient Hearing Profile Information</measure>
    <time_frame>post-implant at 1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Patient Hearing Profile Information related  to hearing history and daily hearing device use</description>
  </other_outcome>
  <other_outcome>
    <measure>General Patient Hearing Profile Information</measure>
    <time_frame>post-implant at 2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>General Patient Hearing Profile Information related  to hearing history and daily hearing device use</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Cochlear® Hearing Implants, hearing loss</arm_group_label>
    <description>Implanted Adolescents and Adults with permanent hearing loss</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cochlear® Hearing Implants</intervention_name>
    <description>Nucleus Cochlear implants, Cochlear Baha implants, Cochlear Acoustic Implants</description>
    <arm_group_label>Cochlear® Hearing Implants, hearing loss</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care routine clinical patients, with permanent hearing loss seeking implant
        treatment for hearing rehabilitation. Adolescent and Adult patients have limited or no
        benefit from conventional acoustic hearing aids.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post-lingually deafened adults and adolescents who are newly implanted AND prior to
             first switch-on of their external device

          -  Unilateral, bilateral simultaneous recipients of any implant device(s) available with
             market approval from the company Cochlear®

          -  Children 10 years or older unless children under 18yrs are excluded through local
             regulations

          -  Mentally capable to respond to self-administered assessment scales

          -  Willingness to participate and sign the Patient Informed Consent form

        Exclusion Criteria:

          -  Individuals excluded from participation in a registry according to national or local
             regulations
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ernst von Wallenberg</last_name>
    <role>Study Director</role>
    <affiliation>Cochlear</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Josephine Wyss</last_name>
    <phone>+41 61 205 0403</phone>
    <email>jwyss@cochlear.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny w Bialymstoku</name>
      <address>
        <city>Bialymstoku</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Dzieciecy w Bydgoszczy</name>
      <address>
        <city>Bydgoszczy</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny nr 1 w Lodzi</name>
      <address>
        <city>Lodzi</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie</name>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 2 w Poznaniu</name>
      <address>
        <city>Poznaniu</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 1 w Szczecinie</name>
      <address>
        <city>Szczecinie</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Parklands Hospital</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Johannesburg Cochlear Implant Center</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stellenbosch University</name>
      <address>
        <city>Tygerberg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcantara</name>
      <address>
        <city>Caceres</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Maranon</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinica Universitad de Navarra</name>
      <address>
        <city>Pamplona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario del Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Poland</country>
    <country>South Africa</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Noble W, Tyler R, Dunn C, Bhullar N. Unilateral and bilateral cochlear implants and the implant-plus-hearing-aid profile: comparing self-assessed and measured abilities. Int J Audiol. 2008 Aug;47(8):505-14. doi: 10.1080/14992020802070770.</citation>
    <PMID>18608531</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>November 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cochlear® Hearing Implants</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
